Solazyme (SZYM) Posts Q2 Loss of $0.43/Share
Get Alerts SZYM Hot Sheet
Join SI Premium – FREE
Solazyme (NASDAQ: SZYM) reported Q2 EPS of ($0.43), $0.07 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $15.9 million versus the consensus estimate of $17.13 million.
For earnings history and earnings-related data on Solazyme (SZYM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- Mangoceuticals closes $500K offering at 74% premium to recent price
- Hunterbrook discloses Meta short position as alternative data signals Muse cooling
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share